Skip to main content

Table 1 Patient characteristics

From: A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use

 

Total population

Quality of life population

Photographed population

 

N=230

N=197

N=177

Age (years)

47.42 (8.40)

47.85 (8.47)

48.09 (8.78)

Sex (Male)

87.0%

86.8%

87.6%

Body Mass Index

21.59 (2.56)

21.62 (2.50)

21.63 (2.45)

Duration of HIV seropositivity (years)

16.00 (4.37)

16.10 (4.29)

16.11 (4.35)

CD4 count (CD4/mm3)

543 (299)

547 (288)

551 (306)

Viral load (< 400 copies/ml)

84.9%

84.7%

84.0%

Time since antiretroviral therapy initiated (years)

11.55 (4.02)

11.69 (3.90)

11.74 (3.98)

  1. Note: Means are provided for continuous variables with standard error of measurement (SEM) in parentheses.